BioCryst Pharmaceuticals

NCT00073944

BCX-1777 in Treating Patients With Refractory Cancer

NCT01289886

Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects

NCT01289899

Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects

NCT00098332

Forodesine (BCX-1777) in Treating Patients With Refractory Stage IIA, Stage IIB, Stage III, Stage IVA, or Stage IVB Cutaneous T-Cell Lymphoma

NCT00937534

Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers

NCT00923533

A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers

NCT00938262

A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

NCT00938197

A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers

NCT00938132

A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers

NCT00991705

A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

NCT00991783

A Study to Evaluate the Effect of Fimasartan on Pharmacokinetics, and the Safety of Digoxin in Healthy Male Volunteers

NCT01007409

A Study to Assess Food Effect on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

NCT01146938

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers

NCT01148368

A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Renal Impairment Patients and Healthy Volunteers

NCT01397214

Pharmacokinetics of Megace F and Megace OS Under Fasting and Fed Conditions in Healthy Male Volunteers

NCT01671020

Clinical Trials for Single Oral Dose of 60mg Fimasartan and Single IV Infusion of 30mg Fimasartan to Evaluate the Absolute Bioavailability of Kanarb® Tablet (Fimasartan) in Healthy Subjects

NCT01921946

To Evaluate the Pharmacokinetic Interactions and Safety Between Fimasartan and Rosuvastatin

NCT02125162

A Study of the Relative Bioavailability of a New Formulation of BCX4161 and the Effect of Food on BCX4161

NCT02205151

To Compare the Pharmacokinetics of Fimasartan/Amlodipine Combination Tablet and Coadministration of Fimasartan and Amlodipine as Individual Tablets

NCT02205190

to Compare the Pharmacokinetics and Safety of Fimasartan/Rosuvastatin Combination Tablet and Coadministration of Fimasartan and Rosuvastatin

NCT02218294

Study to Determine How BCX4161 is Metabolized and Eliminated by the Body

NCT02319772

A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of BCX4430

NCT02397538

Study to Evaluate the Pharmacokinetic Interaction and Safety After Multiple Oral Doses of Fimasartan/Amlodipine and Rosuvastatin in Healthy Male Subjects

NCT02397590

Study to Evaluate the Pharmacokinetic Interaction Between Fimasartan and Atorvastatin in Healthy Male Volunteers

NCT02448264

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BCX7353 in Healthy Western and Japanese Volunteers

NCT02493738

A Clinical Study to Evaluate the Pharmacokinetics of Lozanoc and Sporanox in Korean Healthy Male Volunteers

NCT02566187

A Study to Compare the Pharmacokinetics of Fimasartan/Atorvastatin Combination Tablet

NCT02581696

The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers

NCT02569814

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

NCT02920931

A Randomized, Open-label, Single-dosing, 2X2 Crossover Study to Compare the Safety and Pharmacokinetics of BR-TND Tablet(Tenofovir Disoproxil) With Viread Tablet(Tenofovir Disoproxil Fumarate) in Healthy Male Volunteers

NCT02704702

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Rosuvastatin in Healthy Male Subjects

NCT02819102

An Open-label Drug-Drug Interaction Study to Evaluate the Effect of BCX7353 on Cytochrome P450 Enzyme Activity Using Probe Substrates

NCT02759224

A Study to Compare the Pharmacokinetics of Lafutidine and Irsogladine Maleate Tablet

NCT02995720

A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

NCT02920047

A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Fimasartan and Amlodipine in Healthy Male Subjects

NCT02994745

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Atorvastatin in Healthy Male Volunteers.

NCT03136237

A Drug-Drug Interaction Study to Evaluate Drug Transporter Interactions

NCT03202784

A Relative Bioavailability Study of Two Formulations of BCX7353

NCT03156127

A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

NCT03250052

A Clinical Trial to Evaluate Pharmacokinetic Interactions and Safety Between Fimasartan and Linagliptin in Healthy Male Volunteers

NCT03390465

Drug Interaction Study of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

NCT03609294

A Clinical Trial to Evaluate the Pharmacokinetics and Safety/Tolerability of Fimasartan and Linagliptin in Healthy Volunteers

NCT03629067

Combination of Fimasartan/Amlodipine/Hydrochlorothiazide in Healthy Male Subjects

NCT03718611

To Evaluate the Pharmacokinetics and Safety of Oral Administration of BR9001 Compared With BR900A in Healthy Subjects

NCT03800173

A Study to Evaluate the Single Dose Safety, Tolerability and Pharmacokinetics of IV BCX4430

NCT03891420

A Study to Evaluate the Safety, Pharmacokinetics and Antiviral Effects of Galidesivir in Yellow Fever or COVID-19

NCT04018248

BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)

NCT04485585

A Study to Evaluate Drug-drug Interactions Between BR9006-1 and BR9006-2 in Healthy Male Volunteers.

NCT04846998

A Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

NCT04857047

A Multi Doses Study to Compare the Pharmacokinetics of BR9003A and BR9003 in Healthy Adult Subjects

NCT04889651

A Study to Compare the Pharmacokinetics and Safety Between BR9004 and BR9004-1 in Healthy Male Volunteers

NCT05097794

"A Clinical Trial to Evaluate Drug-drug Interactions and Safety Between BR1015-1 and BR1015-2 in Healthy Volunteers"

NCT05068193

"A Clinical Trial to Compare the Pharmacokinetics and Bioequivalence of BR2008 With BR2008-1 in Healthy Volunteers"

NCT05102903

"A Clinical Trial to Compare the Pharmacokinetics and Safety of BR1016A With BR1016B in Healthy Volunteers"

NCT05102266

"A Clinical Trial to Compare the Pharmacokinetics and Safety of BR1016C With BR1016D in Healthy Volunteers"

NCT05411965

A Study to Evaluate the Pharmacokinetics After Administration of BR3003 and Co-administration of BR3003B and BR3003C.

NCT05372380

A Study to Evaluate Drug-drug Interactions Between BR1017-1 and BR1017-2 in Healthy Volunteers

NCT05460364

A Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1018-1 and BR1018-2 in Healthy Adult Subjects

NCT06165237

"A Study to Evaluate the Drug-drug Interaction and Safety Between BR6001-1 and BR6001-2"

NCT05875259

A Clinical Trial Study to Evaluate the Pharmacokinetic Interaction and Safety Between BR1019-1 and BR1019-2 in Healthy Adult Subjects

NCT05959499

"A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of BR6002 and Coadministration of BR6002A and BR6002B Under Fed Conditions in Healthy Adult Volunteers"

NCT05959486

"A Study to Evaluate the Pharmacokinetics and Safety Between Single Administration of BR6002 and Coadministration of BR6002A and BR6002B Under Fasting Conditions in Healthy Adult Volunteers"

NCT05951946

"A Study to Evaluate Drug-drug Interactions and Safety Between BR3006-1, BR3006-2, and BR3006-3 in Healthy Volunteers"

NCT06008028

"A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions in Healthy Volunteers"

NCT06008015

"A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fed Conditions in Healthy Volunteers"

NCT06100900

Dose Escalation of BCX10013 in Participants with Paroxysmal Nocturnal Hemoglobinuria (PNH)

NCT06184269

"A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1017-1 and Co-administration of BR1017-1A and BR1017-1B"

NCT06226727

"A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1019 and Co-administration of BR1019-1 and BR1019-2"

NCT06289920

"A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of BR3005 and Co-administration of BR3005-1 and BR3005-2 Under Fasting Conditions in Healthy Adult Volunteers"

NCT06289933

"A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of BR3005 and Co-administration of BR3005-1 and BR3005-2 Under Fed Conditions in Healthy Adult Volunteers"

NCT06889064

A Study to Evaluate the Pharmacokinetic, Pharmacodynamic Characteristics and the Safety After Administration by Doses of BR1400-1, BR1400-2, BR1400-3 in Healthy Adult Volunteers

NCT06539507

A Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of BCX17725

NCT06636877

"A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1019 and Co-administration of BR1019-3 and BR1019-2 in Healthy Volunteers"

NCT06879132

A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fed Conditions

NCT06879158

A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fasting Conditions

NCT06890286

A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fasting Conditions

NCT06890299

A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed Conditions

NCT06744127

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 Under Fasting Conditions

NCT06744426

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fasting Conditions

NCT06744062

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-1 and BR1015-2 in Healthy Volunteers Fed Conditions

NCT06744439

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1015 and Co-administration of BR1015-3 and BR1015-2 Under Fed Conditions

NCT06867497

A Study to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety Between Administration of BR2021 and BR2021-1

NCT06889012

A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers

NCT07069335

A Bioequivalence Study to Evaluate Pharmacokinetics and Safety of BR2022 and BR2022-1 in Patients With Deleterious or Suspected Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer

NCT07083388

"A Study to Evaluate the Pharmacokinetics and Safety Between BR3006 and Co-administration of BR3006A, BR3006B, and BR3006C in Healthy Adult Volunteers (Fasting)"

NCT07083401

"A Study to Evaluate the Pharmacokinetics and Safety Between BR3006 and Co-administration of BR3006A, BR3006B, and BR3006C in Healthy Adult Volunteers (Fed)"